Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Antitrust watchdog sets maximum selling price for 50 doses of CoviVac vaccine at $297

FAS has agreed on the maximum selling price for a new package of the CoviVac vaccine. The new form of vaccine release contains 50 doses.

FAS initiated a case in the ALV supply market

The FAS Russia has initiated an antimonopoly case against Hamilton Medical AG on the grounds of coordinating the actions of the manufacturer's official distributors.

FDA warns of clinical trial results showing increased risk of death associated with Pepaxto

Due to the detrimental effect on overall survival in the OCEAN trial, FDA is requiring the manufacturer suspend enrollment in the trial.

ICH releases widely anticipated guidance on continuous manufacturing

Three different models of continuous manufacturing are described in the draft guideline. The guideline incorporates the ICH Q7 definition of a batch to continuous manufacturing.

FAS fined Bayer for improper advertising

The FAS Russia imposed an administrative fine of 200 thousand rubles on Bayer JSC for improper advertising of the medicine Teraflex Hondrokrem Forte.

EMA: vaccine Moderna approved for children aged 12 to 17 in EU

The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above.
spot_img

Expert Articles

spot_img